AWH Aspira Women's Health Inc

Price (delayed)

$1.43

Market cap

$17.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.42

Enterprise value

$16.82M

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Highlights
The EPS has soared by 58% YoY and by 22% from the previous quarter
The net income has grown by 46% year-on-year and by 12% since the previous quarter
The company's quick ratio fell by 38% YoY but it rose by 17% QoQ

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
12.45M
Market cap
$17.8M
Enterprise value
$16.82M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.87
Earnings
Revenue
$8.99M
EBIT
-$14.74M
EBITDA
-$14.6M
Free cash flow
-$14.66M
Per share
EPS
-$1.42
Free cash flow per share
-$1.24
Book value per share
-$0.13
Revenue per share
$0.76
TBVPS
$0.6
Balance sheet
Total assets
$7.16M
Total liabilities
$8.53M
Debt
$2.69M
Equity
-$1.36M
Working capital
$829,000
Liquidity
Debt to equity
-1.97
Current ratio
1.16
Quick ratio
0.98
Net debt/EBITDA
0.07
Margins
EBITDA margin
-162.4%
Gross margin
58.8%
Net margin
-164%
Operating margin
-192.2%
Efficiency
Return on assets
-197.8%
Return on equity
N/A
Return on invested capital
-2,212.2%
Return on capital employed
-788%
Return on sales
-164%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
-1.38%
1 week
2.88%
1 month
-12.27%
1 year
-41.63%
YTD
-64.95%
QTD
-4.03%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$8.99M
Gross profit
$5.29M
Operating income
-$17.28M
Net income
-$14.74M
Gross margin
58.8%
Net margin
-164%
The net margin has increased by 48% year-on-year and by 10% since the previous quarter
The net income has grown by 46% year-on-year and by 12% since the previous quarter
Aspira Women's Health's operating margin has increased by 41% YoY and by 7% from the previous quarter
The operating income has grown by 39% year-on-year and by 8% since the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
1.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.87
The EPS has soared by 58% YoY and by 22% from the previous quarter
The company's equity rose by 42% QoQ
AWH's price to sales (P/S) is 95% less than its 5-year quarterly average of 38.9 and 56% less than its last 4 quarters average of 4.2
Aspira Women's Health's revenue has increased by 4.5% YoY

Efficiency

How efficient is Aspira Women's Health business performance
Aspira Women's Health's ROIC has soared by 57% YoY but it has decreased by 2.5% from the previous quarter
The ROS has grown by 48% YoY and by 10% from the previous quarter
The ROA has contracted by 40% YoY

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 16% less than its total liabilities
The company's quick ratio fell by 38% YoY but it rose by 17% QoQ
Aspira Women's Health's total assets has decreased by 38% YoY but it has increased by 14% from the previous quarter
Aspira Women's Health's debt to equity has plunged by 146% YoY and by 63% from the previous quarter
The company's equity rose by 42% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.